Replies to post #1762 on Glucose Health Inc (GLUC)

[DukeOBass]

One person posting all the hype wants you to invest so he can get his money out before it's too late. Beware!

[DukeOBass]

BAD NEWS for BISU. They took way too long and may be too late to make much out of Type2 Defense.

Johnson & Johnson First to Market with New Class of Type 2 Diabetes Drug

Johnson & Johnson received approval from the U.S. FDA on Friday for Invokana, a medication for the treatment of type 2 diabetes in a new class of drugs, sodium-glucose co-transporter 2 inhibitors, or SGLT2 inhibitors, reported USNews.com .